AbbVie ABBV announced that the phase III VERONA study failed to meet the primary endpoint of overall survival. The study ...

Venclexta, when combined with azacitidine, elicited an overall survival benefit below 10% in patients with myelodysplastic ...

AbbVie (ABBV) said on Monday that its late-stage trial evaluating its drug Venetoclax in combination with Azacitidine in the ...

Annual Sales in US$ Thousand for the Years 2020 through 2027 ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the ...

Myelodysplastic syndrome (MDS) involves abnormal production of blood cells in your bone marrow. MDS is not just one single disease. It is a group of diseases that affect how blood cells are made. In ...

AbbVie's Phase 3 VERONA trial in HR-MDS showed no overall survival benefit for venetoclax-azacitidine; existing uses of ...

If you have MDS, a type of blood cancer called myelodysplastic syndrome, you’re part of a rare group of people with the diagnosis. But research is ongoing. Many clinical trials are seeking new ...

Individuals who smoked had more genetic mutations associated with myelodysplastic syndrome than nonsmokers. Patients with longer smoking histories had a higher number of mutations and greater ...

Bexmarilimab and Vidaza achieved high response rates in higher-risk myelodysplastic syndrome, meeting the phase 2 BEXMAB trial's primary endpoint. The treatment demonstrated a 63% objective response ...

Fred Hutchinson Cancer Center is a world leader in Myelodysplastic Syndrome (MDS) research. Our experts are developing innovative ways to detect and diagnose MDS, unraveling how MDS progresses to ...

The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), but these individuals have a high mortality risk, according to a study ...

The models were tested ... The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), but these individuals have a high mortality ...